Supriya Lifescience Limited
NSE: SUPRIYA · Healthcare
₹791.65
-5.50 (-0.69%)
Last close · 30 Aug 2026, 2:50 am IST
- Open
- ₹797.15
- Day high
- ₹815.00
- Day low
- ₹790.00
- Volume
- 1.16 L
- Prev close
- ₹797.15
Price chart
Range
EMA
Also show
Fundamentals
Biotechnology
Valuation
- Market Cap
- 6,765 Cr
- Price
- 840.50
- P/E (TTM)
- 32.36
- P/E (Fwd)
- 21.12
- P/B
- 5.65
- EV/EBITDA
- 22.76
- EV/Revenue
- 8.09
- PEG
- —
- Div Yield
- 0.12%
- 52W High
- 1,085.00
- 52W Low
- 545.50
- Beta
- 0.63
Profitability & income
- Revenue (TTM)
- 828 Cr
- Net Income (TTM)
- 209 Cr
- EBITDA
- 294 Cr
- Gross Margin
- 69.32%
- Op. Margin
- 32.23%
- Net Margin
- 25.26%
- ROE
- 19.06%
- ROA
- 13.45%
- EPS (TTM)
- 25.97
- EPS (Fwd)
- 39.80
Financial health
- Total Debt
- 5 Cr
- Total Cash
- 79 Cr
- Debt/Equity
- 0.45
- Current Ratio
- 4.40
- Quick Ratio
- 2.47
- Book Value
- 148.77
- Free Cash Flow
- -16 Cr
- Op. Cash Flow
- 186 Cr
Growth
- Revenue Growth
- 50.20%
- Earnings Growth
- 46.70%
- Earnings QoQ
- 47.30%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 277 Cr | 74 Cr | 101 Cr | 89 Cr | 171 Cr | — | 5 Cr | 1,198 Cr |
| 2025-12-31 | 206 Cr | 50 Cr | 74 Cr | 65 Cr | 145 Cr | — | — | — |
| 2025-09-30 | 200 Cr | 50 Cr | 75 Cr | 66 Cr | 144 Cr | — | 5 Cr | 1,082 Cr |
| 2025-06-30 | 145 Cr | 35 Cr | 54 Cr | 45 Cr | 113 Cr | — | — | — |
| 2025-03-31 | 184 Cr | 50 Cr | 71 Cr | 62 Cr | 129 Cr | — | 5 Cr | 997 Cr |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 828 Cr | 209 Cr | 305 Cr | 266 Cr | 574 Cr | 186 Cr | 5 Cr | 1,198 Cr |
| 2025-03-31 | 696 Cr | 188 Cr | 271 Cr | 240 Cr | 485 Cr | 165 Cr | 5 Cr | 997 Cr |
| 2024-03-31 | 557 Cr | 119 Cr | 185 Cr | 158 Cr | 279 Cr | 113 Cr | 5 Cr | 815 Cr |
| 2023-03-31 | 451 Cr | 90 Cr | 137 Cr | 115 Cr | 220 Cr | 64 Cr | 22 Cr | 699 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for SUPRIYA?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in